IP Library › Assignment 034245/0684
Patent Assignment
Reel/Frame 034245/0684

Change of Name

Recorded: 2014-11-14 Pages: 3
Assignor
N30 PHARMACEUTICALS, LLC
Executed: 2012-07-31
Assignee
N30 PHARMACEUTICALS, INC.
3122 STERLING CIRCLE, BOULDER, COLORADO, 80301
Covered Property (1)
Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 9,139,528 →
Application: 14/540,216 →
Publication: US 2015/0080429
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 14, 2014
From: SUN, XICHENG; QIU, JIAN; STOUT, ADAM
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 034245/0676 →
Change of Name Mar 4, 2015
From: N30 PHARMACEUTICALS, INC.
To: NIVALIS THERAPEUTICS, INC.
Reel/Frame 035125/0164 →
Assignment of Assignor's Interest Jul 13, 2018
From: ALPINE IMMUNE SCIENCES, INC.
To: LAUREL VENTURE CAPITAL LTD.
Reel/Frame 046341/0795 →
Assignment of Assignor's Interest Apr 4, 2019
From: LAUREL VENTURE CAPITAL LTD.
To: LAUREL THERAPEUTICS LTD.
Reel/Frame 048787/0883 →